Ann Arbor, MI -- (SBWIRE) -- 04/24/2012 -- Tangent Medical (http://www.tangentmedical.com), an innovator in IV therapy products, today announced its participation (Booth # 329) at the 2012 INS Annual Convention & Industrial Exhibition on April 30 - May 2, 2012 at the Rio Hotel in Las Vegas. The NovaCath™ Secure IV Catheter System, currently under 510(k) review with the FDA, will be unveiled to the public for the first time at this convention. NovaCath is a next-generation technology designed to address current IV therapy challenges including catheter stabilization, occupational exposure to blood, tubing management and patient comfort.

“Up to 50% of all short-peripheral IV catheters develop complications that negatively impact catheter dwell times, clinical outcomes, patient safety and patient satisfaction,” said Curtis Bloch, Vice President of Sales and Marketing for Tangent Medical. “Most industry guidelines and standards recommend the use of catheter stabilization devices to preserve catheter site integrity and reduce complications. Our innovative, closed IV catheter design uniquely integrates advanced catheter stabilization technology, blood control and next generation tubing management on every short-peripheral IV start. The unveiling of NovaCath at INS will create a new paradigm in IV catheter design, functionality and performance.”

When cleared by the FDA, NovaCath will be the first safety IV catheter offering advanced catheter stabilization technology designed to exceed the highest CDC, OSHA and INS standards for IV catheter stabilization. Its passive needle shielding technology and closed system is designed to minimize occupational exposure to blood. Several patent pending design features will uniquely position NovaCath to offer healthcare facilities uncompromising safety and satisfaction – both to the clinician and the patient.

The INS Annual Convention & Industrial Exhibition is the largest convention in the U.S. each year for the infusion specialty. This year between 1,300 and 1,500 infusion nurses from 30 countries will converge on Las Vegas for six days of education sessions, three days of exhibits with industry leaders, poster and abstract presentations showcasing the latest infusion research and plenty of networking opportunities.

About Tangent Medical
Tangent Medical is focused on the development and commercialization of IV therapy products. Founded in 2009 as a spin-out of the University of Michigan’s Medical Innovation Center, the company’s patent-pending NovaCath™ Secure IV Catheter System is the only safety IV catheter to cost-effectively integrate advanced catheter stabilization, passive needle encapsulation, tubing management and blood control. Based on extensive clinical research into the needs of both healthcare workers and patients, this next-generation system is designed to establish a new standard in catheter design, functionality and performance. For more information, visit http://www.tangentmedical.com.